Sentences with word «oclacitinib»

APOQUEL (oclacitinib tablet) is a prescription allergy medicine that provides fast, effective, and safe relief of allergic dog itch.
Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
Long - term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
A blinded, randomized, placebo - controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel ®) in client - owned dogs with atopic dermatitis.
These drugs include antihistamines, steroids (cortisone), cyclosporine, and newer drugs such as oclacitinib.
Jennifer Schissler Pendergraft, DVM, MS, DACVD, and co-investigator Andrew Simpson, DVM, of Colorado State University James L. Voss Veterinary Teaching Hospital, will receive a grant for their project, «Frequency of urinary tract infection in dogs treated with oclacitinib (APOQUEL) for cutaneous hypersensitivity: a prospective study.»
APOQUEL (oclacitinib tablet) is available only through prescription from a veterinarian.
Gadeyne C, Little P, King VL, Edwards N, Davis K, Stegemann MR. Efficacy of oclacitinib (Apoquel ®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client - owned dogs in Australia.
Recent advancements have been made in the area of antipruritic medications for animals and there are now effective medications with fewer long term side effects such as cyclosporine (Atopica) and oclacitinib (Apoquel).
FLORHAM PARK, N.J. — Jan. 20, 2014 — Zoetis Inc. today announced that APOQUEL ® (oclacitinib tablet) is now available to veterinarians in the United States for the control of pruritus, or itching, associated with allergic dermatitis and the control of atopic dermatitis in dogs at least 12 months of age.
Find out more information about the causes of allergic dog itch, APOQUEL (oclacitinib tablet) allergy medicine, how to track the signs, and what to ask your veterinarian right here.
Unlike over-the-counter products, prescription APOQUEL (oclacitinib tablet) dog allergy medicine uniquely targets the source of your dog's allergic itch.
Florham Park, N.J. — August 13, 2013 — Results of a new pivotal study show that APOQUEL ® (oclacitinib tablet) provides effective and safe control of pruritus associated with allergic dermatitis in dogs with a rapid onset of efficacy within 24 hours and without the commonly reported side effects of steroids.
New to the market, oclacitinib, inhibits the cells initiating the itch - scratch cycle by attacking allergies at the cellular level.
MADISON, N.J. — May 16, 2013 — Zoetis, Inc. (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved APOQUEL ® (oclacitinib tablet) for the control of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs at least 12 months of age.
«Six dogs (four oclacitinib and two placebo group) were withdrawn from the study during the continuation phase for abnormal health events.
These products include the recently announced conditional license for Canine Atopic Dermatitis Immunotherapeutic *, a first - of - its - kind antibody therapy to help reduce clinical signs associated with atopic dermatitis in dogs, as well as APOQUEL ® (oclacitinib tablet) and CONVENIA ® (cefovecin sodium).
Abnormal health events were reported in 11 of 179 oclacitinib - treated dogs post-study.
«Efficacy and safety of oclacitinib (APOQUEL) compared to prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client - owned dogs»
«Efficacy and safety of oclacitinib (APOQUEL) compared to cyclosporine (Atopica, Novartis Animal Health) for the control of atopic dermatitis in client - owned dogs»
FLORHAM PARK, N.J., April 8, 2014 — Zoetis will offer two oral presentations and one poster presentation featuring data on APOQUEL ® (oclacitinib tablet), the first and only Janus kinase (JAK) inhibitor approved for veterinary use during the North American Veterinary Dermatology Forum (NAVDF) in Phoenix, Ariz., April 9 — 12.
Apoquel is oclacitinib.
Certain medications the dog might be receiving concurrently (spinosad / Comfortis ®, antifungals medications like itraconazole and ketoconazole, certain antibiotics, corticosteroids, Apoquel ® / oclacitinib, etc.) can make a bad reaction to the avermectins more likely You can read more on the subject of demodectic mange treatment here, here, here and here.
a b c d e f g h i j k l m n o p q r s t u v w x y z